The Safety and Pharmacokinetics of ABI-4334, a Novel Next-Generation HBV Core Inhibitor: Interim Results from a Phase 1 Study in Healthy Volunteers
Journal of hepatology(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of hepatology(2023)